BCAX (NASDAQ: BCAX) insider plans stock sale after option exercise

Rhea-AI Filing Summary

BCAX insider Ryan Cohlhepp has filed a Form 144 notice to sell 3,828 shares of the company’s common stock through UBS Financial Services, Inc. on or about January 22, 2026 on the NASDAQ market. The planned sale has an aggregate market value of 64,961.16 based on the figures reported. These shares were acquired on May 12, 2024 by exercising a stock option from the issuer for cash.

The filing also lists prior sales of BCAX common stock by Cohlhepp during the past three months, including 12,500 shares sold on October 15, 2025 for gross proceeds of 226,942.50 and additional 12,500-share blocks in November and December 2025, plus a smaller sale on January 15, 2026. The notice includes a representation that the seller is not aware of undisclosed material adverse information about the issuer.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc Eleven Madison Avenue 4th Floor New York NY 10010	3828	64961.16	54781950	01/22/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/12/2024	Exercise of Stock Option	Issuer			3828	05/12/2024	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Ryan Cohlhepp 116 HUNTINGTON AVENUE, SUITE 703 Boston MA 02116	Common	10/15/2025	12500	226942.50
Ryan Cohlhepp 116 HUNTINGTON AVENUE, SUITE 703 Boston MA 02116	Common	11/21/2025	12500	225587.50
Ryan Cohlhepp 116 HUNTINGTON AVENUE SUITE 703 Boston MA 02116	Common	12/15/2025	12500	233547.50
Ryan Cohlhepp 116 HUNTINGTON AVENUE SUITE 703 Boston MA 02116	Common	01/15/2026	149	2684.98

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the BCAX Form 144 filing disclose?

The Form 144 discloses that Ryan Cohlhepp intends to sell 3,828 shares of BCAX common stock, with an aggregate market value of 64,961.16, through a broker on or about January 22, 2026.

How were the 3,828 BCAX shares being sold acquired?

The 3,828 common shares to be sold were acquired on May 12, 2024 via an exercise of stock options from the issuer, paid for in cash.

Which broker and exchange are involved in the BCAX Form 144 sale?

The planned sale will be executed through UBS Financial Services, Inc., located at Eleven Madison Avenue, New York, and the shares are listed for sale on the NASDAQ exchange.

What BCAX share sales has Ryan Cohlhepp made in the past 3 months?

The filing reports several prior sales of BCAX common stock by Ryan Cohlhepp over the past three months, including 12,500 shares sold on October 15, 2025 for 226,942.50, plus additional 12,500-share transactions in November and December 2025 and a sale of 149 shares on January 15, 2026.

What representation does the seller make in this BCAX Form 144?

By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about BCAX’s current or prospective operations that has not been publicly disclosed.

What is the reported number of BCAX shares outstanding in the Form 144?

The Form 144 indicates that there are 54,781,950 shares of BCAX common stock outstanding, providing context for the size of the planned sale.